DaVita Inc (NYSE:DVA)
| 73.44 Delayed Data As of Dec 05 |  -0.90 / -1.21%Today’s Change | 65.28 Today|||52-Week Range 124.81 | -35.44% Year-to-Date |
| SECTOR Health Services | INDUSTRY Medical/Nursing Services | MARKET CAP $6.7B |
Company Description
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Contact Information
DaVita, Inc. 2000 16th Street Denver Colorado 80202-7198 |
Employees
Shareholders
| Other institutional | 61.79% |
| Individual stakeholders | 49.34% |
| Mutual fund holders | 26.99% |
Top Executives
| Javier J. Rodriguez | Chief Executive Officer & Director |
| Joel Ackerman | Chief Financial Officer |
| Jeff Giullian | Chief Medical Officer |
| James O. Hearty | Chief Compliance Officer |
| Andrew Mohraz | Associate General Counsel & Head-Investigations |
